Abcodia | detecting cancer earlier
detecting cancer earlier

Follow us


Abcodia - detecting cancer earlier

Abcodia is a specialist company engaged in the discovery and verification of biomarkers for the early detection and screening of cancer. Our mission is to change the way that biomarkers are developed to allow the earlier diagnosis of cancer and help people live longer and healthier lives. For more information about our capability, expertise and approach to cancer screening please download our presentation.

Latest News

University of Manchester

Abcodia and the University of Manchester collaborate on biomarker discovery for lung cancer More


Abcodia appoints President of North America to establish US presence and launch the ROCA® Test More

ROCA® - Screening for Ovarian Cancer

ROCA is a screening test that assesses the likelihood of a woman having ovarian cancer. Read more...


Early Diagnosis Consortium (EDC)

A strategic alliance with Cancer Research UK and Cancer Research Technology to discover and validate biomarkers for cancer screening. Read more...

A Unique Serum Biobank

biobankThe biobank contains over 5 million separate longitudinal serum samples and is available to license. Read more...